Reporting of retrospective registration in clinical trial publications: a cross-sectional study of German trials

被引:8
作者
Haslberger, Martin [1 ]
Gestrich, Stefanie [1 ]
Strech, Daniel [1 ]
机构
[1] Berlin Inst Hlth Charite, QUEST Ctr Responsible Res, Berlin, Germany
来源
BMJ OPEN | 2023年 / 13卷 / 04期
关键词
Medical ethics; Statistics & research methods; Clinical trials; STATEMENT;
D O I
10.1136/bmjopen-2022-069553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Prospective registration has been widely implemented and accepted as a best practice in clinical research, but retrospective registration is still commonly found. We assessed to what extent retrospective registration is reported transparently in journal publications and investigated factors associated with transparent reporting. Design We used a dataset of trials registered in ClinicalTrials.gov or Deutsches Register Klinischer Studien, with a German University Medical Center as the lead centre, completed in 2009-2017, and with a corresponding peer-reviewed results publication. We extracted all registration statements from results publications of retrospectively registered trials and assessed whether they mention or justify the retrospective registration. We analysed associations of retrospective registration and reporting thereof with registration number reporting, International Committee of Medical Journal Editors (ICMJE) membership/-following and industry sponsorship using chi(2) or Fisher exact test. Results In the dataset of 1927 trials with a corresponding results publication, 956 (53.7%) were retrospectively registered. Of those, 2.2% (21) explicitly report the retrospective registration in the abstract and 3.5% (33) in the full text. In 2.1% (20) of publications, authors provide an explanation for the retrospective registration in the full text. Registration numbers were significantly underreported in abstracts of retrospectively registered trials compared with prospectively registered trials. Publications in ICMJE member journals did not have statistically significantly higher rates of both prospective registration and disclosure of retrospective registration, and publications in journals claiming to follow ICMJE recommendations showed statistically significantly lower rates compared with non-ICMJE-following journals. Industry sponsorship of trials was significantly associated with higher rates of prospective registration, but not with transparent registration reporting. Conclusions Contrary to ICMJE guidance, retrospective registration is disclosed and explained only in a small number of retrospectively registered studies. Disclosure of the retrospective nature of the registration would require a brief statement in the manuscript and could be easily implemented by journals.
引用
收藏
页数:9
相关论文
共 25 条
  • [1] Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations
    Al-Durra, Mustafa
    Nolan, Robert P.
    Seto, Emily
    Cafazzo, Joseph A.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [2] Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3
    Battisti, Wendy P.
    Wager, Elizabeth
    Baltzer, Lise
    Bridges, Dan
    Cairns, Angela
    Carswell, Christopher I.
    Citrome, Leslie
    Gurr, James A.
    Mooney, LaVerne A.
    Moore, B. Jane
    Pena, Teresa
    Sanes-Miller, Carol H.
    Veitch, Keith
    Woolley, Karen L.
    Yarker, Yvonne E.
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (06) : 461 - +
  • [3] Birajdar Amit R, 2019, Perspect Clin Res, V10, P26, DOI 10.4103/picr.PICR_163_17
  • [4] Boughton S., 2016, IN PRESS
  • [5] Beware performative reproducibility
    Buck, Stuart
    [J]. NATURE, 2021, 595 (7866) : 151 - 151
  • [6] Clinical trial registration: a statement from the International Committee of Medical journal Editors
    De Angelis, C
    Drazen, JM
    Frizelle, FA
    Haug, C
    Hoey, J
    Horton, R
    Kotzin, S
    Laine, C
    Marusic, A
    Overbeke, AJPM
    Schroeder, TV
    Sox, HC
    Van der Weyden, MB
    [J]. LANCET, 2004, 364 (9438) : 911 - 912
  • [7] European Medicines Agency, 2022, REG EU 536 2014 EUR
  • [8] When are clinical trials registered? An analysis of prospective versus retrospective registration
    Harriman, Stephanie L.
    Patel, Jigisha
    [J]. TRIALS, 2016, 17
  • [9] Haslberger M., 2023, REPORTING RETROSPECT
  • [10] Prospective registration trends, reasons for retrospective registration and mechanisms to increase prospective registration compliance: descriptive analysis and survey
    Hunter, Kylie Elizabeth
    Seidler, Anna Lene
    Askie, Lisa M.
    [J]. BMJ OPEN, 2018, 8 (03):